Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2026-02-20 @ 5:58 PM
Study NCT ID:
NCT02527434
Status:
COMPLETED
Last Update Posted:
2023-11-15
First Post:
2015-08-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Tremelimumab in Patients With Advanced Solid Tumors
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D4884C00001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None